MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-10-0023873
Klokter Life Sciences Private Limited
Klokter Life Sciences Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹27.7 Cr
▲ 74% YoY
Net profit · FY 2024
₹14.78 Lakh
Net margin 0.5%
EBITDA · FY 2024
₹3.05 Cr
EBITDA margin 11%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
35
Provident fund records
Directors on board
4
As per MCA filings
About Klokter Life Sciences Private Limited
Data last updated:
Klokter Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110DL2019PTC357489. Its GSTIN is 06AAHCK8774F1Z6 (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Klokter Life Sciences Limited. It is led by directors including Rajeev Mukul and Verinder Chhabra.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2024, the company reported a revenue of ₹27.7 Cr, a growth of 74% compared to the previous year. For the same year it recorded a net profit of ₹14.78 Lakh (net margin 0.5%) and EBITDA of ₹3.05 Cr (EBITDA margin 11%). Revenue has grown at a compounded annual rate (CAGR) of 738% over three years.
The company has about 35 employees on its provident fund (EPFO) records.
Klokter Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-10-0023873).
Company details
CIN U24110DL2019PTC357489
Registration Number 357489
Incorporation Date 15 November 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Medium
Udyam Registration UDYAM-HR-10-0023873
CIN history
Klokter Life Sciences has one previous CIN (Corporate Identification Number): U24110DL2019PLC357489. The current CIN is U24110DL2019PTC357489, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110DL2019PTC357489 | Current |
| U24110DL2019PLC357489 | Previous |
Recognitions & Rankings of Klokter Life Sciences
Contact details
Klokter Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Klokter Life Sciences Private Limited, buy the company report.
Comprehensive company report
Klokter Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Klokter Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Klokter Life Sciences Private Limited, buy the company report.
Financials of Klokter Life Sciences Private Limited
FY 2024 filings availableKlokter Life Sciences Private Limited reported revenue of ₹27.7 Cr (up 74% YoY) for FY 2024.
Revenue · FY 2024
₹27.7 Cr ▲ 74%
Net profit · FY 2024
₹14.78 Lakh margin 0.5%
EBITDA · FY 2024
₹3.05 Cr margin 11%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 74%
3 years · compounded
▲ 738%
EBITDA CAGR growth
1 year
▲ 772%
3 years · compounded
▲ 179%
Revenue has grown at a compounded annual rate (CAGR) of 738% over three years, including 74% growth in the latest year. EBITDA rose 772% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Klokter Life Sciences Private Limited, buy the company report.
Board of directors of Klokter Life Sciences Private Limited
Klokter Life Sciences has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Mukul Also directs: Palm Land Hotel & Resorts LLP, Klokter Healthcare Private Limited, Lanark Laboratories Pvt Ltd and 5 more | Director | 15 Nov 2019 | 6 Years 11 Months | Current |
| Verinder Chhabra Also directs: Klokter Healthcare Private Limited, Deventure Villas Private Limited, JJ Logistics and Technopark Private Limited and 5 more | Director | 26 May 2023 | 3 Years 4 Months | Current |
| Dinesh Kakar Also directs: Lanark Laboratories Pvt Ltd, JJ Logistics and Technopark Private Limited, Deventure Hotels Private Limited and 5 more | Director | 11 Sep 2020 | 6 Years 1 Months | Current |
| Raman Deep Chaudhary Also directs: Zee Laboratories Limited | Additional Director | 20 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Klokter Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synac Pharmaceuticals Private Limited | ₹27.79 Cr (FY 2025) | 311.0% | Hyderabad, Telangana, India | |||
| Anthea Pharma Private Limited | ₹27.78 Cr (FY 2025) | 516.0% | Hyderabad, Telangana, India | |||
| Nandu Chemicals Private Limited | ₹27.74 Cr (FY 2025) | 16.0% | Hubli, Karnataka, India | |||
| Enzal Chemicals (India) Limited | ₹27.7 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Deep Polychem Private Limited | ₹27.7 Cr (FY 2024) | 12.0% | Delhi, India | |||
| Klokter Life Sciences Private Limitedthis company | ₹27.7 Cr (FY 2024) | ₹14.78 Lakh | 0.5% | 74.0% | 35 | New Delhi, Delhi, India |
| Lifesticks Pharmaceuticals Private Limited | ₹27.68 Cr (FY 2025) | 196.0% | Roorkee, Uttarakhand, India | |||
| Taru Vikas Private Limited | ₹27.68 Cr (FY 2024) | -43.0% | Delhi, India | |||
| Sain Medicaments Private Limited | ₹27.64 Cr (FY 2025) | 4.0% | Telangana, India | |||
| Altra Pharma-Chem Private Limited | ₹27.64 Cr (FY 2024) | -36.0% | Thane, Maharashtra, India | |||
| Jips Pharmaceuticals Private Limited | ₹27.63 Cr (FY 2023) | 19.0% | Chandigarh, India |
To see the full peer comparison of Klokter Life Sciences Private Limited, buy the company report.
Auditor
Klokter Life Sciences Private Limited is audited by Vipin Kumar Mool Chand & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vipin Kumar Mool Chand & Co. | FY 2023 | 036717N |
Shareholding
The shareholding of Klokter Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Klokter Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Klokter Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Klokter Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Klokter Life Sciences Private Limited has a workforce of 35 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
35
Active EPFO establishments
1
Employee growth
-31.37%
GST
Klokter Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCK8774F1Z6 | Haryana | Active | 28 Nov 2019 |
To see the full GST registrations and return filing status of Klokter Life Sciences Private Limited, buy the company report.
Recent activity
Klokter Life Sciences Private Limited has 12 board changes on record since 2019: 6 appointments and 6 cessations. The latest: Raman Deep Chaudhary was appointed as Additional Director on 20 Nov 2025.
Appointed
Raman Deep Chaudhary was appointed as Additional Director.
Appointed
Arun Kumar Verma was appointed as Additional Director.
AGM
Klokter Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Ravi Prakash Chaturvedi ceased to be Additional Director.
Appointed
Ravi Prakash Chaturvedi was appointed as Additional Director.
Filing
Klokter Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi I.
Ceased
Verinder Chhabra ceased to be Additional Director.
Appointed
Verinder Chhabra was appointed as Director.
Ceased
Onkar Prasad Shrivastav ceased to be Additional Director.
Ceased
Rohan Mukul ceased to be Director.
Ceased
Dinesh Kakar ceased to be Additional Director.
Appointed
Dinesh Kakar was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Klokter Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 November 2019 (7+ years old) and is registered under CIN U24110DL2019PTC357489.
Klokter Life Sciences has 4 current directors:
- Rajeev Mukul - Director
- Verinder Chhabra - Director
- Dinesh Kakar - Director
- Raman Deep Chaudhary - Additional Director
The latest financial statements of Klokter Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Klokter Life Sciences is 06AAHCK8774F1Z6, registered in Haryana.
The CIN (Corporate Identification Number) of Klokter Life Sciences is U24110DL2019PTC357489. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Klokter Life Sciences was incorporated on 15 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Klokter Life Sciences by revenue are Synac Pharmaceuticals Private Limited, Anthea Pharma Private Limited, Nandu Chemicals Private Limited, Enzal Chemicals (India) Limited, Deep Polychem Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Raman Deep Chaudhary was appointed as Additional Director on 20 Nov 2025. Arun Kumar Verma was appointed as Additional Director on 20 Feb 2025. Ravi Prakash Chaturvedi ceased to be Additional Director on 20 Sep 2024. Klokter Life Sciences has 12 board changes on record in total.
Yes, Klokter Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-10-0023873).
The registered office of Klokter Life Sciences is at 913 D – Mall Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
Klokter Life Sciences operates in the pharma industry, in the drug formulation and development segment.